Yahoo Web Search

Search results

  1. May 1, 2024 · Clinically, Dr. Kurtz is a medical oncologist who specializes in the treatment of non-Hodgkin lymphomas. He will continue his clinical practice part-time alongside his new role at Foresight....

  2. May 1, 2024 · Dr. Kurtz was one of the earliest investigators to explore the utility of tumor-derived cell-free DNA in lymphomas, with a focus on improving the clinical utility and analytical sensitivity of...

  3. People also ask

  4. May 1, 2024 · BOULDER, Colo., May 1, 2024 /PRNewswire/ -- Foresight Diagnostics™, a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease (MRD) detection, announced today the appointment of David Kurtz, MD, PhD, as its new Chief Medical Officer (CMO) and Head of Research. As one of Foresight's co-founders ...

  5. May 1, 2024 · Foresight Diagnostics appoints Kurtz as chief medical officer. By BizWest Staff. BOULDER — Foresight Diagnostics Inc., a Boulder-based cancer diagnostics company, has appointed David Kurtz as its chief medical officer and head of research.

  6. May 1, 2024 · As one of the company's co-founders, Kurtz led the development of Foresight's PhasED-Seq technology for cancer minimal residual disease detection. Kurtz's previous experience includes his role as assistant professor of medicine at Stanford University.

  7. May 2, 2024 · Foresight Diagnostics: David Kurtz Foresight Diagnostics has appointed David Kurtz as chief medical officer and head of research. As one of the company's cofounders, Kurtz led the development of Foresight's PhasED-seq technology for cancer minimal residual disease detection.

  8. May 10, 2024 · devan glover, kate york, tim bran, khalid yassein, roy kerr, andrew oliver

  1. People also search for